Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gamma-cyclodextrin
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Gamma-cyclodextrin is a cyclic oligosaccharide known for its ability to form inclusion complexes with various molecules. It acts as a host molecule, encapsulating guest molecules within its hydrophobic cavity. This property allows it to increase the water solubility, absorption, and bioavailability of poorly soluble compounds, such as ginsenosides and berberine. It is also utilized in non-pharmaceutical applications, including as an additive in lithium metal batteries to improve ion transference and as a crosslinker in the development of topologically-crosslinked hydrogels. A modified form of gamma-cyclodextrin, Sugammadex, is used to specifically bind and reverse the effects of steroidal muscle relaxants like rocuronium and vecuronium.
- Other names
- γ-CD
02
Targets
GPX4 (Glutathione peroxidase 4)
Beyond the preview
Go deeper on gamma-cyclodextrin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gamma-cyclodextrin.